Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Gastrointest Endosc ; 89(2): 277-285.e2, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30145315

RESUMO

BACKGROUND AND AIMS: Antithrombotic (AT) therapy has been known to increase post-endoscopic resection (ER) bleeding risk; however, there are few studies quantifying the effect of AT agents. This study aimed to analyze the incidence of delayed bleeding (DB) based on AT agents administered and to identify the proper timing of drug cessation. METHODS: Between January 2011 and March 2017, 7752 patients with 8242 lesions underwent ER for single gastric neoplasm. After a 2:1 propensity score matching using age, sex, specimen size, tumor location, diagnosis, chronic kidney disease, and liver cirrhosis, 798 and 399 lesions were classified as belonging to the matched control (MC) group and AT group, respectively. The clinical outcomes were compared between the 2 groups. RESULTS: The DB rate of the MC and AT groups was 6.3% and 10.0%, respectively. There was no significant difference in the early DB rate between the 2 groups; however, the late DB rate of the AT group was higher than the MC group. The continuation group of the AT group had a higher incidence of DB than their matched control subjects (15.9% vs 5.1%; odds ratio, 3.55; 95% confidence interval, 1.24-10.14; P = .018). In patients taking anticoagulants, heparin bridging therapy (HBT) increased the incidence of DB compared with non-HBT (35.7% vs 10.0%; odds ratio, 5.00; 95% confidence interval, 1.11-22.50; P = .036). No thromboembolic events were observed in patients taking AT agents. CONCLUSIONS: Patients receiving AT therapy had a higher incidence of DB than those not receiving AT therapy, especially with the continued administration of AT agents and HBT.


Assuntos
Anticoagulantes/uso terapêutico , Gastroscopia , Inibidores da Agregação Plaquetária/uso terapêutico , Hemorragia Pós-Operatória/epidemiologia , Neoplasias Gástricas/cirurgia , Idoso , Antitrombinas/uso terapêutico , Aspirina/uso terapêutico , Estudos de Casos e Controles , Desprescrições , Ressecção Endoscópica de Mucosa , Inibidores do Fator Xa/uso terapêutico , Feminino , Heparina/uso terapêutico , Humanos , Incidência , Cirrose Hepática/epidemiologia , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Assistência Perioperatória , Pontuação de Propensão , Insuficiência Renal Crônica/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Neoplasias Gástricas/patologia , Tromboembolia/epidemiologia , Fatores de Tempo , Varfarina/uso terapêutico
2.
Can J Infect Dis Med Microbiol ; 2019: 9351801, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31360270

RESUMO

Background/Aim. In Korea, the rate of Helicobacter pylori (H. pylori) eradication has declined steadily as a result of increasing resistance to antibiotics, especially dual resistance to clarithromycin and metronidazole. However, microbiological culture data on drug-resistant H. pylori is lacking. This study evaluated the antimicrobial efficacy of candidate antibiotics against resistant H. pylori strains. Methods. After retrospectively reviewing the data from the Helicobacter Registry in Gil Medical Center (GMC) and Asan Medical Center (AMC), along with 4 reference strains, we selected the 31 single- or multidrug-resistant strains. The susceptibility of the H. pylori strains to seven antibiotics (clarithromycin, metronidazole, levofloxacin, amoxicillin, tetracycline, rifabutin, and furazolidone) and minimum inhibitory concentration were tested using the broth microdilution technique. Results. Among 31 antibiotic resistance strains for H. pylori, there were no strains resistant to rifabutin or furazolidone, which had MICs of <0.008 and 0.5 µg/mL, respectively. Only one tetracycline-resistant strain was found (MIC < 2 µg/mL). Amoxicillin and levofloxacin were relatively less effective against the H. pylori strains compared to rifabutin or furazolidone (resistance rates 22.6%, 1.9%, respectively). Tetracycline showed the relatively low resistance rates (3.2%) for H. pylori strains. Conclusions. Therefore, along with tetracycline which has already been used as a component for second-line eradication regimen for Helicobacter, rifabutin and furazolidone, alone or in combination, could be used to eradicate antibiotic-resistant H. pylori strains where drug-resistant Helicobacter spp. are increasing.

3.
J Gastric Cancer ; 22(1): 24-34, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35425656

RESUMO

Purpose: Total gastrectomy (TG) with lymph node (LN) dissection is recommended for early gastric cancer (EGC) but is not indicated for endoscopic resection (ER). We aimed to identify patients who could avoid TG by establishing a scoring system for predicting lymph node metastasis (LNM) in proximal EGCs. Materials and Methods: Between January 2003 and December 2017, a total of 1,025 proximal EGC patients who underwent TG with LN dissection were enrolled. Patients who met the absolute ER criteria based on pathological examination were excluded. The pathological risk factors for LNM were determined using univariate and multivariate logistic regression analyses. A scoring system for predicting LNM was developed and applied to the validation group. Results: Of the 1,025 cases, 100 (9.8%) showed positive LNM. Multivariate analysis confirmed the following independent risk factors for LNM: tumor size >2 cm, submucosal invasion, lymphovascular invasion (LVI), and perineural invasion (PNI). A scoring system was created using the four aforementioned variables, and the areas under the receiver operating characteristic curves in both the training (0.85) and validation (0.84) groups indicated excellent discrimination. The probability of LNM in mucosal cancers without LVI or PNI, regardless of size, was <2.9%. Conclusions: Our scoring system involving four variables can predict the probability of LNM in proximal EGC and might be helpful in determining additional treatment plans after ER, functioning as a good indicator of the adequacy of treatments other than TG in high surgical risk patients.

4.
Gut Liver ; 16(2): 198-206, 2022 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-34373364

RESUMO

BACKGROUND/AIMS: Postprocedural bleeding is known to be relatively low after argon plasma coagulation (APC) for gastric neoplasms; however, there are few studies proving the effect of antithrombotic agents. This study aimed to analyze the incidence of delayed bleeding (DB) based on antithrombotic agents administered and to identify the risk factors for DB in APC for gastric tumors. METHODS: A total of 785 patients with 824 lesions underwent APC for single gastric neoplasm between January 2011 and January 2018. After exclusion, 719 and 102 lesions were classified as belonging to the non-antithrombotics (non-AT) and AT groups, respectively. The clinical outcomes were compared between the two groups, and we determined the risk factors for DB in gastric APC. RESULTS: Of the total 821 cases, DB occurred in 20 cases (2.4%): 17 cases in the non-AT group and three cases in the AT group (2.4% vs 2.9%, p=0.728). Multivariate analysis of the risk factors for DB confirmed the following significant, independent risk factors: male sex (odds ratio, 7.66; 95% confidence interval, 1.02 to 57.69; p=0.048) and chronic kidney disease (odds ratio, 4.51; 95% confidence interval, 1.57 to 13.02; p=0.005). Thromboembolic events and perforation were not observed in all patients regardless of whether they took AT agents. CONCLUSIONS: AT therapy is acceptably safe in gastric APC because it does not significantly increase the incidence of DB. However, patients with chronic kidney disease or male sex need to receive careful follow-up on the incidence of post-APC bleeding.


Assuntos
Insuficiência Renal Crônica , Neoplasias Gástricas , Coagulação com Plasma de Argônio/efeitos adversos , Fibrinolíticos/efeitos adversos , Humanos , Masculino , Insuficiência Renal Crônica/etiologia , Estudos Retrospectivos , Fatores de Risco , Neoplasias Gástricas/patologia
5.
Clin Endosc ; 53(2): 230-231, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31337195

RESUMO

Endoscopic variceal ligation is the preferred endoscopic treatment method for esophageal variceal bleeding. The incidence of complications such as chest pain, bleeding, stricture formation, and aspiration pneumonia is low. We report a case wherein a malfunctioning multiple-band ligator could have potentially caused damage to the esophageal varices and massive bleeding. The equipment was safely removed using scissors and forceps. To the best of our knowledge, this is the first published report detailing the management of a case of esophageal variceal bleeding.

6.
Clin Endosc ; 50(2): 197-201, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28008164

RESUMO

In most cases of ingested foreign bodies, endoscopy is the first treatment of choice. Moreover, emergency endoscopic removal is required for sharp and pointed foreign bodies such as animal or fish bones, food boluses, and button batteries due to the increased risks of perforation, obstruction, and bleeding. Here, we presented two cases that needed emergency endoscopic removal of foreign bodies without sufficient fasting time. Foreign bodies could not be visualized by endoscopy due to food residue; therefore, fluoroscopic imaging was utilized for endoscopic removal of foreign bodies in both cases.

7.
Korean J Gastroenterol ; 69(1): 74-78, 2017 Jan 25.
Artigo em Coreano | MEDLINE | ID: mdl-28135795

RESUMO

Jejunal variceal bleeding is less common compared with esophagogastric varices in patients with portal hypertension. However, jejunal variceal bleeding can be fatal without treatment. Treatments include surgery, transjugular intrahepatic porto-systemic shunt (TIPS), endoscopic sclerotherapy, percutaneous coil embolization, and balloon-occluded retrograde transvenous obliteration (BRTO). Percutaneous coil embolization can be considered as an alternative treatment option for those where endoscopic sclerotherapy, surgery, TIPS or BRTO are not possible. Complications of percutaneous coil embolization have been reported, including coil migration. Herein, we report a case of migration of the coil into the jejunal lumen after percutaneous coil embolization for jejunal variceal bleeding. The migrated coil was successfully removed using surgery.


Assuntos
Embolização Terapêutica , Hemorragia Gastrointestinal/etiologia , Doenças do Jejuno/terapia , Equipamentos Cirúrgicos/efeitos adversos , Angiografia , Oclusão com Balão , Embucrilato/química , Hemorragia Gastrointestinal/cirurgia , Humanos , Hipertensão Portal/patologia , Doenças do Jejuno/diagnóstico , Neoplasias Hepáticas/terapia , Masculino , Pessoa de Meia-Idade , Escleroterapia , Tomografia Computadorizada por Raios X
8.
Korean J Gastroenterol ; 68(2): 114-8, 2016 Aug 25.
Artigo em Coreano | MEDLINE | ID: mdl-27554220

RESUMO

Primary biliary mucosa-associated lymphoid tissue (MALT) lymphoma is extremely rare. We report a case of primary biliary MALT lymphoma with obstructive jaundice diagnosed by endoscopic biopsy, without surgical intervention. Obstructive jaundice was relieved by endoscopic drainage and endoscopic biopsy was done simultaneously during endoscopic retrograde cholangiopancreatography. Unnecessary surgical intervention can be avoided after pathological confirmation of lymphoma. The patient received radiotherapy, and is alive without any evidence of recurrence or biliary obstruction. Diagnosis of primary biliary lymphoma is very difficult because of its low prevalence. However, it should always be considered as a differential diagnosis, since when an accurate diagnosis is made, unnecessary surgical intervention can be avoided.


Assuntos
Linfoma de Zona Marginal Tipo Células B/diagnóstico , Linfoma de Zona Marginal Tipo Células B/patologia , Abdome/diagnóstico por imagem , Idoso , Ductos Biliares Intra-Hepáticos , Medula Óssea/patologia , Colangiocarcinoma/diagnóstico , Colangiocarcinoma/patologia , Colangiopancreatografia Retrógrada Endoscópica , Colestase/complicações , Colestase/diagnóstico , Diagnóstico Diferencial , Drenagem , Endoscopia Gastrointestinal , Humanos , Imuno-Histoquímica , Icterícia Obstrutiva/patologia , Linfoma de Zona Marginal Tipo Células B/radioterapia , Masculino , Neprilisina/metabolismo , Tomografia por Emissão de Pósitrons , Stents , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa